1-2 of 2
Kazuhisa Fujikawa, MD PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Optimal Treatment Strategy with Nilotinib for Patients with Newly Diagnosed Chronic Myelogenous Leukemia in the Chronic Phase Based on Early Achievement of Deep Molecular Response (MR 4.5 ) : First Report from N-Road, a Phase II Study in Japan

Kaichi Nishiwaki, MD PhD, Kei-Ji Sugimoto, MD PhD, Shigehisa Tamaki, MD PhD, Junichi Hisatake, MD PhD, Hisayuki Yokoyama, MD PhD, Tadahiko Igarashi, MD PhD, Atsushi Shinagawa, MD PhD, Takeaki Sugawara, MD PhD, Satoru Hara, MD PhD, Kazuhisa Fujikawa, MD PhD, Seiichi Shimizu, MD PhD, Yujiri Toshiaki, MD PhD, Arinobu Tojo, MD PhD, Hisashi Wakita, MD PhD
Journal: Blood
Blood (2016) 128 (22): 1925.
https://doi.org/10.1182/blood.V128.22.1925.1925
Published: 2016
Journal Articles

LR11 Is a Potential Serum and Histological Biomarker for Intravascular Large B-Cell Lymphoma

Chikako Ohwada, MD, PhD, Takeharu Kawaguchi, MD, Naomi Shimizu, MD, PhD, Masahiro Takeuchi, MD, PhD, Emiko Sakaida, M.D., PhD., Yusuke Takeda, M.D., PhD., Kazuhisa Fujikawa, MD, PhD, Kosei Matsue, MD, PhD, Morihiro Higashi, M.D., PhD., Jun-Ichi Tamaru, M.D., PhD., Kotaro Yokote, M.D., PhD., Hideaki Bujo, MD, PhD, Chiaki Nakaseko, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 5104.
https://doi.org/10.1182/blood.V120.21.5104.5104
Published: 2012